• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头孢吡肟(马斯平)治疗严重尿路感染]

[Cefepime (maxipime) in the treatment of severe urinary tract infection].

作者信息

Derevianko I I

机构信息

Research Insitute of Urology, Ministry of Public Health of the Russian Federation, Moscow.

出版信息

Antibiot Khimioter. 2003;48(7):24-8.

PMID:14628575
Abstract

Comparative susceptibility of microflora isolates from patients with complicated urinary tract infections to cefepime, other cephalosporins, amikacin, ciprofloxacin and ofloxacin was studied. Isolates in the diagnostic titers (5 x 10(4)-5 x 10(8)) from the patients treated with cefepime as etiotropic monotherapy were identified. The treatment course was 7 to 14 days. The daily dose was 1 to 2 g. The clinical and bacteriological efficacies of the cefepime therapy equaled to 93.2 and 85.4% respectively.

摘要

研究了复杂性尿路感染患者分离出的微生物对头孢吡肟、其他头孢菌素、阿米卡星、环丙沙星和氧氟沙星的敏感性。对接受头孢吡肟作为病因特异性单一疗法治疗的患者,在诊断滴度(5×10⁴ - 5×10⁸)下分离出的菌株进行了鉴定。疗程为7至14天。日剂量为1至2克。头孢吡肟治疗的临床和细菌学有效率分别为93.2%和85.4%。

相似文献

1
[Cefepime (maxipime) in the treatment of severe urinary tract infection].[头孢吡肟(马斯平)治疗严重尿路感染]
Antibiot Khimioter. 2003;48(7):24-8.
2
[Bacterial flora in urinary tract infections of children and susceptibility to drugs].[儿童尿路感染中的细菌菌群及药物敏感性]
Med Dosw Mikrobiol. 1994;46(1-2):67-71.
3
[Effectiveness of cefpirome in the treatment of complicated infections of the upper and lower urinary tracts].头孢匹罗治疗上、下尿路感染复杂性感染的有效性
Antibiot Khimioter. 1996;41(12):30-3.
4
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.2004年11月至2006年4月在美国一项临床研究中登记的复杂性尿路感染或急性肾盂肾炎患者的病原体鉴定及治疗前易感性
Clin Ther. 2007 Oct;29(10):2215-21. doi: 10.1016/j.clinthera.2007.10.008.
5
Activity of cefepime compared with other antibiotics against gram-positive bacteria and cefuroxime-resistant gram-negative bacteria.头孢吡肟与其他抗生素对革兰氏阳性菌及耐头孢呋辛革兰氏阴性菌的活性比较。
Zhonghua Yi Xue Za Zhi (Taipei). 1998 Jul;61(7):408-13.
6
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).用头孢吡肟对北美医疗中心收集的65746株临床分离细菌进行测试的效力和谱图趋势:哨兵抗菌监测计划(1998 - 2003年)的结果
Diagn Microbiol Infect Dis. 2005 Jul;52(3):265-73. doi: 10.1016/j.diagmicrobio.2005.02.003.
7
[Imipenem and cefepime in empirical therapy of infectious complications after radical surgeries in patients with invasive cancer of the urinary bladder].[亚胺培南与头孢吡肟用于浸润性膀胱癌患者根治性手术后感染性并发症的经验性治疗]
Antibiot Khimioter. 2004;49(8-9):48-51.
8
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
J Chemother. 1997 Dec;9(6):403-10. doi: 10.1179/joc.1997.9.6.403.
9
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.成人复杂性尿路感染的治疗:两项随机、双盲、多中心试验的联合分析,比较厄他培南和头孢曲松随后进行适当口服治疗的效果。
J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii67-74. doi: 10.1093/jac/dkh208.
10
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.头孢洛林对与复杂性皮肤和皮肤结构感染相关病原体的活性:一项国际监测研究的结果。
J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv17-31. doi: 10.1093/jac/dkq252.